Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16956339 | 0.82 | CES2 (0.58) | CES2CES1BCHE | |
| SCHEMBL145728 | 0.79 | CES2 (0.61) | CES2CES1BCHE | |
| SCHEMBL1433488 | 0.78 | CES2 (0.54) | CES2CES1BCHE | |
| SCHEMBL671906 | 0.78 | CES2 (0.67) | CES2CES1BCHE | |
| SCHEMBL31599525 | 0.78 | CES2 (0.54) | CES2CES1BCHE | |
| SCHEMBL16951772 | 0.76 | CES2 (0.52) | CES2CES1BCHE | |
| SCHEMBL6738277 | 0.75 | CES2 (0.56) | CES2CES1BCHE | |
| SCHEMBL7744985 | 0.75 | CES2 (0.70) | CES2CES1BCHEEPHX2 | |
| SCHEMBL16958815 | 0.75 | CES2 (0.50) | CES2CES1BCHE | |
| SCHEMBL11317429 | 0.73 | CES2 (0.48) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915331-B1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-7939695-B2 | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO K.K. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2010-06-10 | — | — | US | disclosed |
| EP-1915331-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | Showa Denko K.K. (JP) | 2008-04-30 | — | — | EP | disclosed |
| WO-2006137348-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2006-12-28 | — | — | WO | disclosed |
| US-6828467-B2 | Industrial process of the hydrogenolysis of one hydroxyl or methanol group of a fluorinated benzenedimethanol carried out in a solvent in the presence of a catalyst; 2,3,5,6-tetra-fluorobenzyl alcohol from the 4-methyl derivative | SHOWA DENKO K.K. (JP) | 2004-12-07 | — | — | US | disclosed |
| EP-1322584-B1 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | SHOWA DENKO K.K. (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1322584-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | Showa Denko K.K. (JP) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002026678-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | ADH1C, ADH5, ADH1A | CES2 436/4885CES1 808/4885BCHE 200/4885 |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | NPM1, MED1, KPNA2 | CES2 1868/4885CES1 2776/4885BCHE 1966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.